Big Move For Rani Therapeutics Holdings Inc.
Wed, Jan 26, 2022 at 05:30 PM
Rani Therapeutics Holdings Inc. (RANI:NASDAQ) jumped higher at $23.14, representing a gain of 19.6%. The stock got featured on our News Catalysts scanner on Wed, Jan 19, 2022 at 07:37 AM in the 'BIOTECH' category. From Wed, Jan 12, 2022, the stock recorded 37.50% Up Days and 55.56% Green Days
About Rani Therapeutics Holdings Inc. (RANI:NASDAQ)
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics.
Top 10 Gainers:
- OmniLit Acquisition Corp. (OLIT:NASDAQ), 100%
- Ebang International Holdings Inc. (EBON:NASDAQ), 35.44%
- Eros STX Global Corporation A (ESGC:NYSE), 30.24%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 26.28%
- K12 Inc. (LRN:NYSE), 25.04%
- Larimar Therapeutics Inc. (LRMR:NASDAQ), 21.25%
- Groupon, Inc. (GRPN:NASDAQ), 20.02%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 19.81%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 19.59%
- Evolus, Inc. (EOLS:NASDAQ), 17.26%